Examples of using Advanced or metastatic in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
This study included 331 patients with unresectable locally advanced or metastatic MTC.
Faslodex is used to treat advanced or metastatic breast cancer in postmenopausal women.
The precise mechanism of action of vandetanib in locally advanced or metastatic MTC is unknown.
It is used for locally advanced or metastatic NSCLC in patients who have already been treated with chemotherapy.
The studies included approximately 800 patients with advanced or metastatic cancer of the pancreas.
Halaven is used to treat locally advanced or metastatic breast cancer which has continued to spread after at least one previous treatment for advanced cancer.
The indication applied for was the treatment of patients with advanced or metastatic pancretic cancer.
Faslodex is used to treat locally advanced or metastatic breast cancer in women who have been through the menopause.
COMETRIQ is indicated for the treatment of adult patients with progressive,unresectable locally advanced or metastatic medullary thyroid carcinoma.
Faslodex is used for the treatment of locally advanced or metastatic breast cancer in postmenopausal women women who have been through the menopause.
Of the patientsenrolled in these studies, the patients described below had received prior systemic therapy for locally advanced or metastatic disease.
Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin.
Efficacy of paclitaxel/cisplatin combination has been demonstrated in two randomised, controlled trials in patients with locally advanced or metastatic NSCLC.
Tyverb was studied in one main study involving 408 women with advanced or metastatic breast cancer that was expressing large quantities of ErbB2.
It is used to treat advanced or metastatic breast cancer(cancer that has spread to other parts of the body) in adults who previously received trastuzumab and a taxane type of cancer medicine.
Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas”.
As monotherapy for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen or for whom further anthracycline therapy is not indicated.
Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non small cell lung cancer.
In the first study, Halaven was compared with other treatments in 762 women with advanced or metastatic breast cancer, who had previously undergone at least two other treatments, which included an anthracycline and a taxane.
The CHMP considered the data submitted in support of the bladder cancer indication andnoted that all the submitted studies were conducted in patients with locally advanced or metastatic bladder cancer.
It is mainly used for the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and for the treatment of pancreatic cancer.
For the treatment of locally advanced or metastatic non small cell lung cancer, Alimta was compared with gemcitabine(another anticancer medicine), in combination with cisplatin, in a study involving 1,725 patients who had not received chemotherapy before.
The randomised phase III INTEREST study was conducted in patients with locally advanced or metastatic NSCLC who had previously received platinum-based chemotherapy.
In one main study of 370 adults with advanced or metastatic transitional cell carcinoma of the urothelial tract, patients who were given Javlor treatment were compared with patients who were not given any anticancer medicine.
DOCETAXEL KABI monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy.
Gemcitabine is indicated in locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence free interval of at least 6 months after-platinum based, first-line therapy”.
Tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic non- small cell lung cancer(NSCLC) with EGFR activating mutations.
Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy.
Gemcitabine, in combination with c isplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer NSCLC.
In one main study involving 1,217 adult patients with locally advanced or metastatic non-small cell lung cancer, Iressa was compared with a combination of carboplatin and paclitaxel other anticancer medicines.